Price T Rowe Associates Inc. MD Sells 125,824 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Price T Rowe Associates Inc. MD lessened its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 0.9% during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 14,469,612 shares of the medical equipment provider's stock after selling 125,824 shares during the quarter. Intuitive Surgical makes up 0.9% of Price T Rowe Associates Inc. MD's holdings, making the stock its 16th largest holding. Price T Rowe Associates Inc. MD owned about 4.06% of Intuitive Surgical worth $7,552,560,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also made changes to their positions in ISRG. Bennett Selby Investments LP increased its stake in Intuitive Surgical by 3.9% in the 4th quarter. Bennett Selby Investments LP now owns 449 shares of the medical equipment provider's stock worth $234,000 after buying an additional 17 shares during the period. Onefund LLC raised its stake in shares of Intuitive Surgical by 1.9% during the fourth quarter. Onefund LLC now owns 947 shares of the medical equipment provider's stock valued at $494,000 after acquiring an additional 18 shares in the last quarter. LVW Advisors LLC boosted its holdings in shares of Intuitive Surgical by 1.3% in the fourth quarter. LVW Advisors LLC now owns 1,448 shares of the medical equipment provider's stock valued at $756,000 after purchasing an additional 19 shares during the period. Wesbanco Bank Inc. grew its stake in Intuitive Surgical by 1.6% in the fourth quarter. Wesbanco Bank Inc. now owns 1,216 shares of the medical equipment provider's stock worth $635,000 after purchasing an additional 19 shares in the last quarter. Finally, FSM Wealth Advisors LLC increased its holdings in Intuitive Surgical by 3.7% during the 4th quarter. FSM Wealth Advisors LLC now owns 526 shares of the medical equipment provider's stock worth $275,000 after purchasing an additional 19 shares during the period. 83.64% of the stock is currently owned by institutional investors.

Insider Activity

In related news, EVP Robert Desantis sold 11,545 shares of the business's stock in a transaction on Thursday, March 13th. The shares were sold at an average price of $499.22, for a total transaction of $5,763,494.90. Following the completion of the transaction, the executive vice president now directly owns 5,224 shares in the company, valued at $2,607,925.28. The trade was a 68.85 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Amal M. Johnson sold 4,635 shares of the stock in a transaction dated Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total value of $2,626,191.00. Following the sale, the director now directly owns 12,275 shares in the company, valued at $6,955,015. This represents a 27.41 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 33,754 shares of company stock valued at $17,691,621 in the last ninety days. Insiders own 0.70% of the company's stock.

Wall Street Analysts Forecast Growth

Several analysts recently weighed in on the company. Robert W. Baird decreased their price objective on Intuitive Surgical from $707.00 to $600.00 and set an "outperform" rating for the company in a report on Tuesday, March 18th. Truist Financial dropped their price objective on shares of Intuitive Surgical from $666.00 to $605.00 and set a "buy" rating on the stock in a research note on Monday, March 17th. JPMorgan Chase & Co. increased their target price on Intuitive Surgical from $575.00 to $675.00 and gave the company an "overweight" rating in a research report on Friday, January 24th. Jefferies Financial Group boosted their price target on Intuitive Surgical from $475.00 to $575.00 in a research report on Monday, January 27th. Finally, CICC Research started coverage on Intuitive Surgical in a research report on Monday, January 27th. They set a "neutral" rating and a $550.00 price objective on the stock. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and fifteen have given a buy rating to the company's stock. According to data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average target price of $611.81.

Intuitive Surgical Stock Performance

Shares of ISRG opened at $478.74 on Wednesday. The stock has a 50-day moving average of $517.55 and a two-hundred day moving average of $532.24. The stock has a market cap of $170.52 billion, a P/E ratio of 74.69, a P/E/G ratio of 5.85 and a beta of 1.55. Intuitive Surgical, Inc. has a one year low of $367.39 and a one year high of $616.00.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 EPS for the quarter, beating analysts' consensus estimates of $1.71 by $0.10. Intuitive Surgical had a return on equity of 14.55% and a net margin of 27.81%. The firm had revenue of $2.25 billion for the quarter, compared to analyst estimates of $2.19 billion. During the same quarter in the prior year, the firm earned $1.50 earnings per share. Analysts predict that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.